Pharmacologically Controlled Drinking in the Treatment of Alcohol Dependence or Alcohol Use Disorders: A Systematic Review With Direct and Network Meta-Analyses on Nalmefene, Naltrexone, Acamprosate, Baclofen and Topiramate

Addiction - United Kingdom
doi 10.1111/add.13974
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Systematic Review of Naltrexone for Attenuating Alcohol Consumption in Women With Alcohol Use Disorders

Alcoholism: Clinical and Experimental Research
MedicinePsychiatryMental HealthToxicology
2017English

The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence, Europe Versus the Rest of the World: A Meta-Analysis

Addiction
MedicinePsychiatryMental Health
2015English

Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence

CNS and Neurological Disorders - Drug Targets
MedicineNeurosciencePharmacology
2010English

Review: Acamprosate and Naltrexone Are Safe and Effective but Have Low Compliance Rates for People With Alcohol Dependence

Evidence-Based Mental Health
PsychiatryMental Health
2005English

Nalmefene: A New Approach to the Treatment of Alcohol Dependence

Substance Abuse and Rehabilitation
2014English

Naltrexone for 3 or 12 Months Did Not Reduce Drinking in Alcohol Dependence

Evidence-Based Medicine
Medicine
2002English

Low-Dose Baclofen for Treatment of Alcohol Dependence

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2017English

Use of Baclofen for Alcohol Use Disorders in the United States

Frontiers in Psychiatry
PsychiatryMental Health
2018English

Nalmefene and Alcohol Dependence: A New Approach or the Same Old Unacceptable Marketing?

Substance Abuse and Rehabilitation
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy